PharmaGroup Holding ApS: Financial statements 2025
CVR: 43581791
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PharmaGroup Holding ApS (CVR 43581791) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 400,274 and a net result of DKK 6,422,018 compared with DKK 6,126,742 the year before. That is an increase of 249.8% compared with the year before. Equity in the 2025 report amounted to DKK 18,214,868. The solvency ratio was 83.5%.
- Gross Profit
- DKK 400,274
- Profit/Loss
- DKK 6,422,018
- Equity
- DKK 18,214,868
- Total Assets
- DKK 21,821,760
- Employees
- 0
Official annual report
How creditworthy is PharmaGroup Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PharmaGroup Holding ApS has published its annual report for 2024. Gross profit came to DKK 114,444, and the net result was DKK 6,126,742.
As of April 24, 2025, KOA CPH ApS has been appointed auditor of PharmaGroup Holding ApS.
As of April 24, 2025, KOA Rådgivning & Regnskab ApS has stepped down as auditor of PharmaGroup Holding ApS.
About PharmaGroup Holding ApS
PharmaGroup Holding ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Amar Fakhry Alaa Al Dyen-Ahmad. The company is owned by Amar Fakhry Alaa Al Dyen-Ahmad. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 400,274 and a net result of DKK 6,422,018 compared with DKK 6,126,742 the year before. Equity in the 2025 report amounted to DKK 18,214,868.